• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型吲哚-查尔酮类贝特类降脂药物的设计与合成

Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.

作者信息

Sashidhara Koneni V, Dodda Ranga Prasad, Sonkar Ravi, Palnati Gopala Reddy, Bhatia Gitika

机构信息

Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow, Uttar pradesh 226031, India.

Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow, Uttar pradesh 226031, India.

出版信息

Eur J Med Chem. 2014 Jun 23;81:499-509. doi: 10.1016/j.ejmech.2014.04.085. Epub 2014 May 14.

DOI:10.1016/j.ejmech.2014.04.085
PMID:24871900
Abstract

A series of novel indole-chalcone fibrates were synthesized and their hypolipidemic activity was evaluated in triton WR-1339 induced hyperlipidemic rat model. Preliminary studies indicated that the hybrids 19, 24 and 29 exhibited potent in vitro antioxidant and significant in vivo antidyslipidemic effects. Our results suggest that these new hybrid architectures may serve as promising leads for the development of next generation lipid lowering agents.

摘要

合成了一系列新型吲哚-查尔酮纤维酸酯,并在 Triton WR-1339 诱导的高脂血症大鼠模型中评估了它们的降血脂活性。初步研究表明,化合物 19、24 和 29 表现出强大的体外抗氧化活性和显著的体内抗血脂异常作用。我们的结果表明,这些新的杂化结构可能成为开发下一代降脂药物的有前景的先导化合物。

相似文献

1
Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.新型吲哚-查尔酮类贝特类降脂药物的设计与合成
Eur J Med Chem. 2014 Jun 23;81:499-509. doi: 10.1016/j.ejmech.2014.04.085. Epub 2014 May 14.
2
Discovery of amide based fibrates as possible antidyslipidemic and antioxidant agents.发现酰胺类纤维酸酯作为可能的抗血脂异常和抗氧化剂。
Eur J Med Chem. 2012 Nov;57:302-10. doi: 10.1016/j.ejmech.2012.09.040. Epub 2012 Oct 3.
3
Hybrid benzofuran-bisindole derivatives: new prototypes with promising anti-hyperlipidemic activities.苯并呋喃-双吲哚衍生物的混合物:具有良好降脂活性的新型原型物。
Eur J Med Chem. 2013 Oct;68:38-46. doi: 10.1016/j.ejmech.2013.07.009. Epub 2013 Jul 30.
4
Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic, LDL-oxidation and antioxidant activity.合成新穿心莲内酯衍生物及其抗血脂异常、LDL 氧化和抗氧化活性的评价。
Eur J Med Chem. 2013 Nov;69:439-48. doi: 10.1016/j.ejmech.2013.09.002. Epub 2013 Sep 12.
5
Synthesis and antidyslipidemic activity of chalcone fibrates.查耳酮类纤维酸酯的合成及抗脂解作用。
Bioorg Med Chem Lett. 2011 Jun 1;21(11):3475-8. doi: 10.1016/j.bmcl.2011.03.057. Epub 2011 Mar 31.
6
Indole-based fibrates as potential hypolipidemic and antiobesity agents.吲哚类贝特作为有潜力的降脂和抗肥胖药物。
J Med Chem. 2012 Mar 22;55(6):2769-79. doi: 10.1021/jm201697v. Epub 2012 Mar 2.
7
Synthesis of new N-acryl-1-amino-2-phenylethanol and N-acyl-1-amino-3-aryloxypropanols and evaluation of their antihyperlipidemic, LDL-oxidation and antioxidant activity.合成新型 N-丙烯酰基-1-氨基-2-苯乙醇和 N-酰基-1-氨基-3-芳氧基丙醇,并评价其抗高血脂、LDL 氧化和抗氧化活性。
Eur J Med Chem. 2014 Jun 10;80:135-44. doi: 10.1016/j.ejmech.2014.04.020. Epub 2014 Apr 8.
8
Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation.发现具有抗高血脂和抗氧化活性的新型 PPARα 激动剂 4-苄氧基和 4-(2-苯乙氧基)查耳酮纤维酸盐杂合体:设计、合成及体外/体内生物学评价。
Bioorg Chem. 2021 Oct;115:105170. doi: 10.1016/j.bioorg.2021.105170. Epub 2021 Jul 16.
9
Synthesis and in Vivo Lipid-Lowering Activity of Novel Imidazoles-5-carboxamide Derivatives in Triton-WR-1339-Induced Hyperlipidemic Wistar Rats.新型咪唑-5-甲酰胺衍生物在 Triton-WR-1339 诱导的高脂血症 Wistar 大鼠中的合成及体内降脂活性
Chem Pharm Bull (Tokyo). 2018;66(10):953-958. doi: 10.1248/cpb.c18-00346.
10
Synthesis of Novel Benzimidazole-2-carboxamide Derivatives and in Vivo Antihyperlipidemic Activity Evaluation.新型苯并咪唑-2-甲酰胺衍生物的合成及体内抗高血脂活性评价
Chem Pharm Bull (Tokyo). 2018;66(4):423-426. doi: 10.1248/cpb.c17-00908.

引用本文的文献

1
Significance of Chalcone Scaffolds in Medicinal Chemistry.查尔酮骨架在药物化学中的意义。
Top Curr Chem (Cham). 2024 Jun 27;382(3):22. doi: 10.1007/s41061-024-00468-7.
2
Drugs for Diabetes: From Pharmacology to Clinical Application.糖尿病药物:从药理学到临床应用
Pharmaceuticals (Basel). 2023 Sep 24;16(10):1346. doi: 10.3390/ph16101346.
3
The Small Molecule PPARγ Agonist GL516 Induces Feeding-Stimulatory Effects in Hypothalamus Cells Hypo-E22 and Isolated Hypothalami.小分子过氧化物酶体增殖物激活受体 γ 激动剂 GL516 可在 Hypo-E22 下丘脑细胞和离体下丘脑组织中诱导摄食刺激作用。
Molecules. 2022 Jul 30;27(15):4882. doi: 10.3390/molecules27154882.
4
Synthesis and biological evaluation of halogenated phenoxychalcones and their corresponding pyrazolines as cytotoxic agents in human breast cancer.合成及卤代苯并二氢吡喃酮和其相应的吡唑啉类化合物作为人乳腺癌细胞毒剂的生物评价。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):189-201. doi: 10.1080/14756366.2021.1998023.
5
Increased fecal indole concentration in women with gestational diabetes: a pilot study.妊娠期糖尿病女性粪便中吲哚浓度升高:一项初步研究。
Acta Diabetol. 2021 Feb;58(2):241-243. doi: 10.1007/s00592-020-01632-3. Epub 2020 Nov 20.
6
Synthesis of 3-alkenylindoles through regioselective C-H alkenylation of indoles by a ruthenium nanocatalyst.通过钌纳米催化剂对吲哚进行区域选择性C-H烯基化反应合成3-烯基吲哚。
Beilstein J Org Chem. 2020 Jan 29;16:140-148. doi: 10.3762/bjoc.16.16. eCollection 2020.
7
Chalcone Derivatives Enhance ATP-Binding Cassette Transporters A1 in Human THP-1 Macrophages.查尔酮衍生物增强人 THP-1 巨噬细胞中的三磷酸腺苷结合盒转运蛋白 A1。
Molecules. 2018 Jul 3;23(7):1620. doi: 10.3390/molecules23071620.
8
Chalcone Derivatives: Promising Starting Points for Drug Design.查尔酮衍生物:药物设计的理想起始点
Molecules. 2017 Jul 25;22(8):1210. doi: 10.3390/molecules22081210.
9
Chalcone: A Privileged Structure in Medicinal Chemistry.查尔酮:药物化学中的一种优势结构。
Chem Rev. 2017 Jun 28;117(12):7762-7810. doi: 10.1021/acs.chemrev.7b00020. Epub 2017 May 10.
10
Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation.新型合成查耳酮可诱导携带KRAS突变的A549非小细胞肺癌细胞凋亡。
Bioorg Med Chem Lett. 2016 Dec 1;26(23):5703-5706. doi: 10.1016/j.bmcl.2016.10.063. Epub 2016 Oct 24.